17 insiders reported 151 Form 4 transactions for SOLENO THERAPEUTICS INC (SLNO) over the past 18 months (most recent 2026-05-18). Recent activity: Manning Meredith (Chief Commercial Officer) Sell 64,507 shares, Sinclair Andrew (Director) Sell 10,491 shares, Anish Bhatnagar (CHIEF EXECUTIVE OFFICER) Sell 583,656 shares, Yen Kristen (SEE REMARKS) Sell 37,639 shares, Bir Dawn Carter (Director) Sell 16,991 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | Manning Meredith | Chief Commercial Officer | Sell | 64,507 | $0 |
| 2026-05-18 | Sinclair Andrew | Director | Sell | 10,491 | $0 |
| 2026-05-18 | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Sell | 583,656 | $0 |
| 2026-05-18 | Yen Kristen | SEE REMARKS | Sell | 37,639 | $0 |
| 2026-05-18 | Bir Dawn Carter | Director | Sell | 16,991 | $0 |
| 2026-05-18 | Pauls Matthew | Director | Sell | 10,491 | $0 |
| 2026-05-18 | Volck Birgitte | Director | Sell | 17,536 | $0 |
| 2026-05-18 | Hahn Mark W | Director | Sell | 10,046 | $0 |
| 2026-05-18 | Hirano Patricia C | SEE REMARKS | Sell | 22,702 | $0 |
| 2026-05-18 | Norrett Kevin | Chief Business Officer | Sell | 17,786 | $0 |
| 2026-05-18 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | Sell | 39,200 | $0 |
| 2026-05-18 | Joshi Manher | Chief Development Officer | Sell | 20,171 | $0 |
| 2026-05-18 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 39,823 | $0 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 4,256 | $127,850 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 1,838 | $57,052 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 488 | $15,479 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | Sell | 4,864 | $146,115 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | Sell | 2,100 | $65,184 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | Sell | 558 | $17,700 |
| 2026-03-04 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | Buy | 39,200 | $0 |
| 2026-01-23 | Huang Michael F. | Sr. VP of Clinical Development | Buy | 10,400 | $0 |
| 2026-01-23 | Joshi Manher | Chief Development Officer | Buy | 4,100 | $0 |
| 2026-01-23 | Mackaness James H | CHIEF FINANCIAL OFFICER | Buy | 28,600 | $0 |
| 2026-01-23 | Hirano Patricia C | SEE REMARKS | Buy | 10,400 | $0 |
| 2026-01-23 | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Buy | 114,200 | $0 |
Source: SEC Form 4 filings · as of 2026-05-18